Adelphi Research is proud to support the Multiple Myeloma Research Foundation and its CureCloud research study as it brings its relentless focus to the democratization of myeloma care to find a cure for each and every patient diagnosed with multiple myeloma.

The MMRF CureCloud is a bold new initiative which will integrate vast amounts of health data from thousands of multiple myeloma patients in the first at-home genomic testing program to inform smarter treatment options, faster, for each multiple myeloma patient. It is the first, largest and most comprehensive database of its kind in myeloma. It is also an invaluable resource to the scientists, doctors and patients working to find treatments, improve patient quality of life and ultimately develop cures. The MMRF designed the CureCloud to reach directly to patients and enroll them online, no matter where they live. Every patient, not just those with access to academic medical centers, will benefit from the CureCloud.

Founded in 1998, the MMRF continues to blaze new trails in pursuit of a cure, acting with urgency to ensure every patient has the solutions they need to take the next step and find the right treatment. A nonprofit, the MMRF’s innovative methods and relentless focus on better outcomes for patients have helped bring many FDA-approved therapies to market, almost tripling life expectancy for some patients.